×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | 3.25 | -4.52 | NA | -18.44 | 0 | |
| GUJARAT THEMIS BIOSYN LTD. | 390.84 | 119.98 | 377.36 | 1.10 | 4,077 | 83.6 |
| HIKAL LTD. | 5,529.00 | 503.00 | 5,524.00 | 4.08 | 4025 | 44.3 |
| Advanced Enzyme Technologies L | 917.36 | 110.54 | 872.06 | 0.99 | 3900 | 29.8 |
Gujarat Themis Biosyn Ltd., with Security Code 506879, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 28.2 | 28.2 | 49.6 | 39.7 | 38.9 | 42.0 | 38.8 | 34.7 | 39.5 | 37.7 |
| Expenses | 16.1 | 13.2 | 26.1 | 22.8 | 21.1 | 21.1 | 20.3 | 19.3 | 20.7 | 21.6 |
| Operating Profit | 12.1 | 14.9 | 23.5 | 16.8 | 17.7 | 20.9 | 18.6 | 15.4 | 18.9 | 16.1 |
| OPM % | 43% | 52.98% | 47.4% | 42.42% | 45.67% | 49.82% | 47.78% | 44.34% | 47.74% | 42.76% |
| Other Income | 1.8 | 1.4 | 1.1 | 1.0 | 1.0 | 1.0 | 0.5 | 0.3 | 0.2 | 1.3 |
| Interest | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Depreciation | 0.7 | 0.8 | 0.7 | 0.9 | 1.0 | 0.9 | 1.1 | 1.4 | 1.6 | 1.2 |
| Profit before tax | 13.2 | 15.5 | 23.8 | 16.9 | 17.7 | 20.9 | 17.9 | 14.2 | 17.4 | 16.2 |
| Tax % | -25.6% | -24.7% | -25.6% | -25.7% | -26.5% | -24.2% | -25.9% | -25.5% | -25.4% | -24.9% |
| Net Profit | 9.8 | 11.7 | 17.7 | 12.5 | 13.0 | 15.9 | 13.2 | 10.6 | 13.0 | 12.0 |
| EPS in Rs | 6.75 | 8.05 | 12.2 | 8.63 | 1.79 | 2.19 | 1.82 | 0.97 | 1.19 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 12% |
| 3 Years: | 10% |
| TTM: | -11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 16% |
| 3 Years: | 4% |
| TTM: | -18% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 48% |
| 5 Years: | 66% |
| 3 Years: | 78% |
| 1 Year: | 21% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|